Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -425.72% is 150% below its 5-year average of -170.51%, near the high end of its 5-year range (-2937.05%–-9.02%).
26.09% below its 12-month average of -337.63%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -225.98%.
OPERATING MARGIN
-425.72%
OPERATING MARGIN AVG TTM
-337.63%
OPERATING MARGIN AVG 3Y
-215.14%
OPERATING MARGIN AVG 5Y
-170.51%
OPERATING MARGIN AVG 10Y
-89.14%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-26.09%
CURRENT VS 3Y AVG
-97.88%
CURRENT VS 5Y AVG
-149.67%
CURRENT VS 10Y AVG
-377.60%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 496 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Coherus Oncology, Inc.
Market Cap
$173.04M
Operating Margin
-425.72%
TTM Avg
-337.63%
3Y Avg
-215.14%
5Y Avg
-170.51%
Market Cap
$172.99M
Operating Margin
0.00%
TTM Avg
-3330.88%
3Y Avg
-1665.44%
5Y Avg
-1110.29%
Market Cap
$174.17M
Operating Margin
-152.19%
TTM Avg
-95.13%
3Y Avg
-132.07%
5Y Avg
-169.10%
Market Cap
$176.96M
Operating Margin
-96.56%
TTM Avg
-271.71%
3Y Avg
-1442.10%
5Y Avg
-1248.16%
Market Cap
$179.70M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$162.82M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-615.66%
Market Cap
$184.12M
Operating Margin
-13.21%
TTM Avg
-18.79%
3Y Avg
-19.38%
5Y Avg
-19.19%
Market Cap
$160.82M
Operating Margin
-8.45%
TTM Avg
-10.66%
3Y Avg
-19.64%
5Y Avg
-13.31%
Market Cap
$153.84M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-91.83%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Coherus Oncology, Inc. (CHRS) | $173.04M | -425.72% | -337.63% | -215.14% | -170.51% |
| Compass Therapeutics, Inc. (CMPX)vs › | $172.99M | 0.00% | -3330.88% | -1665.44% | -1110.29% |
| Precision BioSciences, Inc. (DTIL)vs › | $174.17M | -152.19% | -95.13% | -132.07% | -169.10% |
| Cue Biopharma, Inc. (CUE)vs › | $176.96M | -96.56% | -271.71% | -1442.10% | -1248.16% |
| Canton Strategic Holdings Inc (CNTN)vs › | $179.70M | 0.00% | 0.00% | 0.00% | 0.00% |
| ALX Oncology Holdings Inc. (ALXO)vs › | $162.82M | 0.00% | 0.00% | 0.00% | -615.66% |
| Journey Medical Corporation (DERM)vs › | $184.12M | -13.21% | -18.79% | -19.38% | -19.19% |
| Inogen, Inc. (INGN)vs › | $160.82M | -8.45% | -10.66% | -19.64% | -13.31% |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $153.84M | 0.00% | 0.00% | 0.00% | -91.83% |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $192.97M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
63.5%
Operating Margin
-425.7%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -225.98% |
| 2026-03-31 | -293.67% |
| 2025-12-31 | -359.90% |
| 2025-09-30 | -364.99% |
| 2025-06-30 | -443.59% |
| 2025-03-31 | -597.91% |
| 2024-12-31 | -78.03% |
| 2024-09-30 | -9.02% |
| 2024-06-30 | -31.56% |
| 2024-03-31 | -2937.05% |
| 2023-12-31 | -75.29% |
| 2023-09-30 | -42.92% |
| 2023-06-30 | -58.83% |
| 2023-03-31 | -208.86% |
| 2022-12-31 | -113.54% |
| 2022-09-30 | -177.11% |
| 2022-06-30 | -73.17% |
| 2022-03-31 | -134.62% |
| 2021-12-31 | -53.90% |
| 2021-09-30 | -39.74% |
| 2021-06-30 | -27.57% |
| 2021-03-31 | -201.56% |
| 2020-12-31 | 14.88% |
| 2020-09-30 | 29.69% |
| 2020-06-30 | 48.14% |
| 2020-03-31 | 35.18% |
| 2019-12-31 | 36.36% |
| 2019-09-30 | 46.42% |
| 2019-06-30 | 32.95% |
| 2019-03-31 | -44.74% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | -4060.07% |
| 2017-03-31 | -44979.50% |
| 2016-12-31 | -8703.79% |
| 2016-09-30 | 51.96% |
| 2016-06-30 | -445.95% |
| 2016-03-31 | -520.69% |
| 2015-12-31 | -511.93% |
| 2015-09-30 | -993.68% |
| 2015-06-30 | -857.78% |
| 2015-03-31 | -632.50% |
| 2014-12-31 | -409.06% |
| 2014-09-30 | -40.01% |
| 2014-06-30 | -361.29% |
| 2014-03-31 | -382.68% |
| 2013-12-31 | -851.22% |
| 2013-09-30 | -1340.51% |
| 2013-06-30 | -1831.16% |
| 2013-03-31 | -1865.42% |
